स्वास्थ्य तक पहुँच और सामर्थ्य

Also filed elsewhere

• Anemia Mukt Bharat Abhiyaan: from 6x6x6 to 7x7x7 · on गैर संचारी रोग, पोषण और खाद्य सुरक्षा

  Anemia Mukt Bharat ran for eight years on a 6x6x6 strategy: six beneficiary groups, six interventions and six institutional mechanisms, with prophylactic iron and folic acid supplementation at its centre.

• Cancer: a seventeenth State makes it notifiable, and the WHO counts the world · on गैर संचारी रोग, पोषण और खाद्य सुरक्षा

  A notifiable disease is one that every doctor and hospital must report to the State when they diagnose it.

• Central licensing of cell and gene therapies · on जीनोमिक्स, जीन संपादन और कोशिका चिकित्सा

  Under the Drugs and Cosmetics Act, 1940 most drug manufacturing licences are given by State drug controllers.

• Regulating medicines: cough syrups, fixed dose combinations and QR codes · on औषधि, नैदानिकी और चिकित्सा प्रौद्योगिकी

  In June 2026 the Ministry of Health and Family Welfare announced four changes to how medicines are regulated.

• Draft National Health Research Policy, 2026: six times the money, judged by impact · on स्वास्थ्य प्रणालियाँ और अनुसंधान

  Health research in India is funded and steered by the Department of Health Research and the Indian Council of Medical Research under a National Health Research Policy of 2011.

• Drones for tuberculosis samples: diagnosis in five days, not fifteen · on औषधि, नैदानिकी और चिकित्सा प्रौद्योगिकी

  Exam lens: i-DRONE is the ICMR's drone programme; India's tuberculosis elimination target is 2025 under the National TB Elimination Programme; sputum microscopy and molecular tests are the diagnostics.

• Leptospirosis in Kerala · on संचारी रोग, पशु स्वास्थ्य और वन हेल्थ

  Exam lens: a bacterial zoonosis from animal urine in water; not person to person; peaks after floods; treated with antibiotics.

• National Viral Hepatitis Control Programme: the birth dose crosses 92 per cent · on संचारी रोग, पशु स्वास्थ्य और वन हेल्थ

  Exam lens: the programme began in 2018 with elimination by 2030; the hepatitis B birth dose within 24 hours; B and C are blood borne, A and E water borne; hepatitis C is curable with direct acting antivirals.

• Particulate matter and the placenta · on वायु प्रदूषण

  Exam lens: PM2.5 is particulate matter 2.5 micrometres or less across; epigenetic changes alter how genes are expressed without changing the DNA sequence.

• India's first dengue vaccine: Qdenga and the four serotype problem · on टीके और प्रतिरक्षण

  In July 2026 the Central Drugs Standard Control Organisation granted marketing authorisation to Qdenga, a live attenuated tetravalent dengue vaccine made by Takeda, a Japanese company, at its plant in Germany, for people aged 4 to 60.

• GLP-1 drugs: semaglutide goes generic in India, and the first quality test · on औषधि, नैदानिकी और चिकित्सा प्रौद्योगिकी

  On 9 July 2026 Dr Reddy's Laboratories paused supplies of its generic semaglutide in India and Canada after batches failed specification because of a problem with the active ingredient, and Torrent Pharmaceuticals recalled batches of a pen that Dr Reddy's makes for it.

• Stem cell therapy: what is proven and who regulates it · on जीनोमिक्स, जीन संपादन और कोशिका चिकित्सा

  A stem cell is an unspecialised cell that can both renew itself by dividing and turn into a specialised cell such as a blood, nerve or muscle cell.

• Summer air pollution: PM10 and ozone · on वायु प्रदूषण

  Summer air pollution in India is driven by coarse PM10 and ground level ozone, where winter pollution is dominated by fine PM2.5 trapped by cold, still air.